The FDA has approved Zycubo (copper histidinate) injection as the first and only treatment of Menkes disease in pediatric ...

After a series of personal misconduct allegations, a former Stanford professor resigned from his position as Director of the ...

The US Food and Drug Administration yesterday approved the Zycubo (copper histidinate) injection as the first treatment for Menkes disease in pediatric patients. The FDA approved Zycubo, previously ...

PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

Vanda Pharma announces receipt of US FDA decision letter on Hetlioz sNDA for jet lag disorder: Washington Saturday, January 10, 2026, 13:00 Hrs [IST] Vanda Pharmaceuticals Inc. (V ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Amid an FDA shakeup and reports ...

Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") . Such ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

This past week in healthcare investigations ...

Dr. Makary’s right-hand man at the FDA, Dr. Vinay Prasad, has long expressed similar thoughts, writing: ...

New York, New York-- (Newsfile Corp. - January 15, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") ...